AGP Executive Report
Last update: 18 minutes agoFederal Rescheduling Deadline: A key U.S. marijuana rescheduling fight hits a Monday deadline for post-hearing briefs in the DEA process that could shift marijuana from Schedule I to Schedule III, with major implications for patients, researchers, and state-legal markets. Hemp Crackdown in Hawaii: Hawaii officials are defending a crackdown on hemp-derived products after a lawsuit challenges the state’s move to restrict THC items sold without medical cards. Nebraska Budget Bill Pushback: Nebraska’s LB1072, which would sweep major fund transfers and reshape programs, faces strong opposition in the Legislature. Industry M&A Watch: Curaleaf’s $272M bid for Aurora Cannabis keeps consolidation pressure on the medical cannabis sector. Enforcement Roundup: Police raids across multiple regions net cannabis and other drugs, including a Mumbai hydroponic lab bust tied to YouTube methods and a Galway operation seizing about €233,000 in cannabis. Product Safety/Youth Access: A guest op-ed highlights concerns about intoxicating hemp-derived cannabinoid products marketed to young people without rigorous testing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
